Sector valuations Caplin Point Laboratories Limited NSE India S.E.
Stocks
CAPLIPOINT
INE475E01026
Pharmaceuticals
|
Market Closed -
NSE India S.E.
07:05:07 2026-09-23 EDT
|
5-day change | 1st Jan Change | ||
| 2,793.80 INR | +0.59% |
|
+8.16% | +51.99% |
| 08-14 | Caplin Point Laboratories Limited, Q1 2027 Earnings Call, Aug 12, 2026 | |
| 08-12 | Caplin Point Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2026 | CI |
Main competitors
| P/E (Y) | Price to Book (Y) | PEG (Y) | EV / Sales (Y) | EV / EBITDA (Y) | EV / EBIT (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|
 | 34.07x | 4.77x | 2.55x | 6.39x | 22.15x | 26.83x | 0.93% | 46.34B | |
| 15.9x | 1.77x | 7.61x | 1.97x | 8.74x | 11.09x | 1.7% | 37.12B | |
| 27.87x | 3.84x | -1.67x | 3.97x | 16.47x | 23.07x | 0.58% | 12.13B | |
| 26.94x | 2.98x | 3.84x | 3.27x | 16.92x | 21.71x | 0.94% | 11.7B | |
| 18.55x | 3.38x | 3.14x | 3.36x | 11.73x | 13.95x | 3.8% | 8.99B | |
| 9.27x | 1.53x | 1.33x | 2.14x | 5.54x | 6.74x | 4.79% | 7.25B | |
| 29.94x | 5.49x | 0.43x | 3.92x | 18.23x | 21.97x | 0.16% | 7.27B | |
| 15.18x | 1.27x | 2.52x | 2.01x | 6.67x | 9.46x | 3.28% | 7.13B | |
| 35.1x | 8.12x | 1.88x | 6.84x | 25.02x | 27.63x | 0.99% | 4.6B | |
| 16.2x | 0.79x | -0.03x | 2.22x | 9.52x | 12.05x | 1.67% | 4.36B | |
| 14.39x | 2.39x | 0.52x | 2.38x | 10.71x | 10.53x | 3.64% | 3.8B | |
| 15.95x | 2.83x | -9.5x | 3.22x | 12.15x | 14.49x | 3.06% | 2.79B | |
| 19.18x | 4.86x | 4.31x | 5.47x | 16.39x | 17.92x | 3.15% | 2.48B | |
| 29.81x | - | -0.12x | - | - | - | - | 2.31B | |
| 13.21x | - | -0.86x | 9.26x | 9.09x | 9.37x | - | 2.33B | |
| Average | 21.44x | 3.39x | 1.06x | 4.03x | 13.52x | 16.20x | 2.21% | 10.71B | |
| Weighted average by Cap. | 24.04x | 3.39x | 2.97x | 4.03x | 14.96x | 18.42x | 1.66% |
Select your edition
All financial news and data tailored to specific country editions
